Navidea Biopharmaceuticals Inc (NAVBQ)

[DewDiligence]

>> In this case he doesn't like this stock, I don't really care but for this stock he says the market has it right. <<

What the market finally got right is not the valuation per se, but rather the realization that the technically-open BLA doesn’t mean squat.

For all practical purposes, the RIGS BLA can be considered de novo; there is a new pivotal trial and (later) there will be a new CMC submission.

I like the stock a lot more now than I did at double the price before the FDA meeting.